Compare Kentanix Supra International Tbk. (KSIX) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kentanix Supra International Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Kentanix Supra International Tbk. trades at Rp406 (market cap 867.96B, 81.6K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kentanix Supra International Tbk. is far larger — about 8.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KSIX | SCPI | |
|---|---|---|
Market Cap | 867.96B | 104.4B |
Volume | 81.6K | — |
Lot | 816 | — |
Turnover | 33.19M | — |
Average Price | 406.78 | — |
Value | 33.19M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kentanix Supra International Tbk.
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Read more on KSIX →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
